Last reviewed · How we verify
perfalgan
At a glance
| Generic name | perfalgan |
|---|---|
| Also known as | Paracetamol |
| Sponsor | Cairo University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Preterm Infants' Paracetamol Study (PHASE2)
- Comparison of the Analgesic Efficacy of Dexketoprofen Trometamol, Meperidine, and Paracetamol in Renal Colic (PHASE4)
- Efficacy Of M-TAPA and TAP Block Following Laparoscopic Cholecystectomy (NA)
- Comparison of Modified Perichondral Approach Thoracoabdominal Nerve Block and Transversus Abdominal Plane Block in Analgesia Management Following Caesarean Section Surgery (NA)
- Efficacy of Modified Perichondral Approach Thoracoabdominal Nerve Block For Post Cesarean Section (NA)
- PECs Block for Pacemaker Insertion in Children (PHASE4)
- Comparison of the Efficacy of Intravenous Paracetamol and Ibuprofen in the Treatment of Fever Due to Upper Respiratory Tract Infection (PHASE4)
- Evidence Based Management of Acute Biliary Pancreatitis
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- perfalgan CI brief — competitive landscape report
- perfalgan updates RSS · CI watch RSS
- Cairo University portfolio CI